GlassScriptPhysician profile
Brian K Park
NPI 1477871655
$2,322.50
in general payments reported to CMS, 2019-2025
7 companies · $884 in 2025
The $884 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2023: $197 · 2024: $668 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.15 |
| Education | $255.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,086.07 | 2023-2025 | Persona, Rosa, Avenir |
| Stryker Corporation | $794.53 | 2021-2025 | Profyle, T2 Alpha, Pangea |
| Medical Device Business Services, INC. | $143.72 | 2024 | Altalyne |
| Globus Medical, INC. | $143.34 | 2025 | Alif |
| Linvatec Corporation | $115.00 | 2025 | Biobrace 23mm |
| Bone Support INC. | $20.46 | 2025 | Ceramentbone Void Filler, Cerament G |
| Vertex Pharmaceuticals Incorporated | $19.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.